Daré Bioscience, Inc. (DARE)
2.01
+0.01
(+0.50%)
USD |
NASDAQ |
Jun 11, 13:25
Daré Bioscience Profit Margin (Quarterly) : -1.97K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -1.97K% |
| December 31, 2025 | -140.8% |
| September 30, 2025 | -154.9K% |
| June 30, 2025 | |
| March 31, 2025 | -17.24K% |
| September 30, 2024 | -11.28K% |
| June 30, 2024 | |
| March 31, 2024 | -72.64K% |
| December 31, 2023 | -279.8% |
| September 30, 2023 | -829.9% |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 4.14% |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 |
| Date | Value |
|---|---|
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | -645.6% |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | -22.43K% |
| March 31, 2014 | -6.20K% |
| December 31, 2013 | -55.40K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eton Pharmaceuticals, Inc. | 6.40% |
| ANI Pharmaceuticals, Inc. | 11.55% |
| Corcept Therapeutics, Inc. | -18.92% |
| Assertio Holdings, Inc. | -189.8% |
| Veru, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -49.00% |
| Return on Invested Capital | -250.0% |
| Gross Profit Margin (Quarterly) | -422.6% |
| Operating Margin (Quarterly) | -1.97K% |
| Return on Net Operating Assets | -187.2% |